focus -WSS

focus

author：leisure time 2025-09-30 08:50:00 - browse：74

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Second House panel advances two

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Glen Campbell's doctor discusses his public struggle with Alzheimer's

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

focus

focus

Sponsor introduction

Featured speakers

Sponsored By

explore

Duchenne breakthrough therapy leaves behind pioneering families

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

What does generative AI mean for health care? We asked experts

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

As demand for Covid shots wanes, Moderna seeks its next success

Biden's order seeks to regulate AI risk without stifling innovation

Medical leaders decry Supreme Court decision on affirmative action

Solving academic medical centers' existential crisis

Affirmative action in medical school literally saved lives

Testing for cancer recurrence creates a new limbo for patients

explore

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Meta's Zuckerberg and Chan on track to put $50 billion into science

Data integrity in scientific journals requires "effort" by publishers, institutions

It's time to retire 'poor historian' from clinicians' vocabularies

Traditional Chinese medicine benefits explored in new JAMA study

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

hotspot

focus

hotspot

Wikipedia